Statistics
Publications
39
Citations
2.7K
H-Index
27
Active since
1993
Linda A. deGraffenried is an author at The University of Texas at Austin specializing in oncology, medicine, and molecular oncology.
Publications per year
1993–2024
39
39
Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.
Josep Maria Peralba, Linda A. deGraffenried, William E. Friedrichs et al. · PubMed · 2003 · 179 citations
Medicine, Oncology, Pharmacology +17
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling
M. Beeram, Qing Tan, RR Tekmal et al. · Annals of Oncology · 2007 · 171 citations
Medicine, Oncology, Pharmacology +17
1–5 of 39